Objective. —To examine the relationship between adherence to a medical regimen and mortality following a myocardial infarction in women. Design. —Analysis of the female cohort entered into a randomized double-blind multicenter trial. Setting. —National Heart, Lung, and Blood Institute β-Blocker Heart Attack Trial. Participants. —The 602 women, aged 30 to 69 years, enrolled in the β-Blocker Heart Attack Trial. Intervention. —Random assignment to propranolol hydrochloride or placebo 5 to 21 days following a myocardial infarction. Measurements. —Adherence for each patient was calculated as the mean of all quarterly adherence estimates during the course of the trial (median follow-up, 26 months). Adherence was classified as good (taking ≥75% of medication) or poor (taking P≤.02). Conclusions. —The independent effect of adherence on mortality following a myocardial infarction in women is clinically substantial, statistically significant, and similar in magnitude to that reported earlier for men. (JAMA. 1993;270:742-744)